Showing results (1-10 of 651) with videos related to
Sort By:
Pageof 66
BMJ Case Reports|June 25, 2017
Obesity-related hypogonadism: a reversible conditionStamatios Zouras, Jeffrey W Stephens, David PriceBMJ Case Reports|November 6, 2017
Anti-LGI1 encephalitis causing faciobrachial dystonic seizuresStamatios Zouras, Jeffrey W Stephens, Srinivasa Rao Abburu, et al.Frontiers in Endocrinology|November 10, 2018
Thyroid Screening in Early Pregnancy: Pros and ConsPeter N Taylor, Stamatios Zouras, Thinzar Min, et al.Patient Preference and Adherence|April 3, 2010
Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectivesMahamood Edavalath, Jeffrey W StephensAACE Clinical Case Reports|January 23, 2020
GRANULOMATOUS DISEASE OF UNUSUAL SITES CAUSING HYPERCALCEMIA: TWO CASE REPORTSStamatios Zouras, Ashutosh Surya, Hussam Abusahmin, et al.Diabetes, Obesity & Metabolism|December 23, 2003
Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease riskPhilippa J Talmud, Jeffrey W StephensExpert Opinion on Pharmacotherapy|September 22, 2015
Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetesDavid M Williams, Jeffrey W StephensExpert Opinion on Drug Safety|August 11, 2007
Safety and adverse effects associated with GLP-1 analoguesJeffrey W Stephens, Stephen C BainExpert Opinion on Drug Metabolism & Toxicology|February 16, 2016
Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetesRose Anderson, Jennifer Hayes, Jeffrey W StephensDrug Design, Development and Therapy|August 4, 2016
Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapyJennifer Hayes, Rosie Anderson, Jeffrey W StephensPageof 66